Leukotriene E4-induced Airway Hyperresponsiveness of Guinea Pig Tracheal Smooth Muscle to Histamine and Evidence for Three Separate Sulfidopeptide Leukotriene Receptors

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1984 Aug 1

PMID 6087352

Citations 29

Authors

T H Lee

K F Austen

E J Corey

J M Drazen

Affiliations

Soon will be listed here.

Abstract

Bronchial hyperresponsiveness to contractile agonists and nonspecific irritants is a characteristic feature of bronchial asthma. The mechanisms causing this hyperirritability are unknown. The existence of separate receptors for leukotrienes C4 and D4 (LTC4 and LTD4) has been demonstrated previously by physiologic and radioligand binding studies. The rank order of potency of the sulfidopeptide leukotrienes for contracting tracheal spirals [leukotriene E4 (LTE4) greater than LTD4 = LTC4] is different from that for contracting parenchymal strips (LTD4 greater than LTE4 greater than LTC4), thereby suggesting the existence of a separate receptor for LTE4. We now report that LTE4, the most stable of the leukotrienes comprising slow reacting substance of anaphylaxis, enhances the contractile response of guinea pig tracheal spirals but not of parenchymal strips to histamine in a time- and dose-dependent fashion. The ability of LTE4 to increase histamine responsiveness occurred after removal of the free agonist and recovery of the tissues to baseline tensions and was not produced by leukotrienes C4 and D4, which elicited the same magnitude of contraction of tracheal smooth muscle as LTE4. These findings suggest that LTE4-induced airway hyperirritability is not mediated by the contractile response per se and may be mediated through a receptor distinct from those for leukotrienes C4 and D4.

Citing Articles

Leukotriene D paradoxically limits LTC-driven platelet activation and lung immunopathology.

Liu T, Barrett N, Nagai J, Lai J, Feng C, Boyce J J Allergy Clin Immunol. 2020; 148(1):195-208.e5.

PMID: 33285161 PMC: 8175451. DOI: 10.1016/j.jaci.2020.10.041.

Expression of COX-1, COX-2, 5-LOX and in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease.

Vorsprach M, Arens C, Knipping S, Jechorek D, Stegemann-Koniszewski S, Lucke E Allergy Asthma Clin Immunol. 2020; 15:83.

PMID: 31889962 PMC: 6933683. DOI: 10.1186/s13223-019-0395-5.

Leukotriene receptors as potential therapeutic targets.

Yokomizo T, Nakamura M, Shimizu T J Clin Invest. 2018; 128(7):2691-2701.

PMID: 29757196 PMC: 6025999. DOI: 10.1172/JCI97946.

Factors driving the aspirin exacerbated respiratory disease phenotype.

Steinke J, Borish L Am J Rhinol Allergy. 2015; 29(1):35-40.

PMID: 25590316 PMC: 4288232. DOI: 10.2500/ajra.2015.29.4123.

Cysteinyl leukotrienes and their receptors; emerging concepts.

Kanaoka Y, Boyce J Allergy Asthma Immunol Res. 2014; 6(4):288-95.

PMID: 24991451 PMC: 4077954. DOI: 10.4168/aair.2014.6.4.288.

References

Lewis R, Drazen J, Figueiredo J, Corey E, Austen K . A review of recent contributions on biologically active products of arachidonate conversion. Int J Immunopharmacol. 1982; 4(2):85-90. DOI: 10.1016/0192-0561(82)90055-8. View

Parker C, BILBO R, Reed C . METHACHOLINE AEROSOL AS TEST FOR BRONCHIAL ASTHMA. Arch Intern Med. 1965; 115:452-8. DOI: 10.1001/archinte.1965.03860160078013. View

Fleisch J, Rinkema L, Baker S . Evidence for multiple leukotriene D4 receptors in smooth muscle. Life Sci. 1982; 31(6):577-81. DOI: 10.1016/0024-3205(82)90487-8. View

Griffin M, Weiss J, Leitch A, McFadden Jr E, Corey E, Austen K . Effects of leukotriene D on the airways in asthma. N Engl J Med. 1983; 308(8):436-9. DOI: 10.1056/NEJM198302243080807. View

Krilis S, Lewis R, Corey E, Austen K . Bioconversion of C-6 sulfidopeptide leukotrienes by the responding guinea pig ileum determines the time course of its contraction. J Clin Invest. 1983; 71(4):909-15. PMC: 436948. DOI: 10.1172/jci110845. View

Creese B, Bach M . Hyperreactivity of airways smooth muscle produced in vitro by leukotrienes. Prostaglandins Leukot Med. 1983; 11(2):161-9. DOI: 10.1016/0262-1746(83)90016-1. View

Empey D, Laitinen L, Jacobs L, Gold W, Nadel J . Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976; 113(2):131-9. DOI: 10.1164/arrd.1976.113.2.131. View

Murphy R, Hammarstrom S, Samuelsson B . Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979; 76(9):4275-9. PMC: 411556. DOI: 10.1073/pnas.76.9.4275. View

Boushey H, Holtzman M, Sheller J, Nadel J . Bronchial hyperreactivity. Am Rev Respir Dis. 1980; 121(2):389-413. DOI: 10.1164/arrd.1980.121.2.389. View

10.

Morris H, Taylor G, Piper P, Tippins J . Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature. 1980; 285(5760):104-6. DOI: 10.1038/285104a0. View

11.

Lewis R, Austen K, Drazen J, Clark D, Marfat A, Corey E . Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci U S A. 1980; 77(6):3710-4. PMC: 349688. DOI: 10.1073/pnas.77.6.3710. View

12.

Drazen J, Austen K, Lewis R, Clark D, GOTO G, Marfat A . Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980; 77(7):4354-8. PMC: 349833. DOI: 10.1073/pnas.77.7.4354. View

13.

Lewis R, Drazen J, Austen K, Clark D, Corey E . Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity. Biochem Biophys Res Commun. 1980; 96(1):271-7. DOI: 10.1016/0006-291x(80)91210-3. View

14.

Parker C, Falkenhein S, Huber M . Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187. Prostaglandins. 1980; 20(5):863-86. DOI: 10.1016/0090-6980(80)90139-2. View

15.

Holroyde M, ALTOUNYAN R, Cole M, Dixon M, ELLIOTT E . Bronchoconstriction produced in man by leukotrienes C and D. Lancet. 1981; 2(8236):17-8. DOI: 10.1016/s0140-6736(81)90254-3. View

16.

Krell R, Osborn R, Vickery L, Falcone K, ODonnell M, Gleason J . Contraction of isolated airway smooth muscle by synthetic leukotrienes C4 and D4. Prostaglandins. 1981; 22(3):387-409. DOI: 10.1016/0090-6980(81)90101-5. View

17.

Weiss J, Drazen J, Coles N, McFadden Jr E, Weller P, Corey E . Bronchoconstrictor effects of leukotriene C in humans. Science. 1982; 216(4542):196-8. DOI: 10.1126/science.7063880. View

18.

Pong S, DeHaven R, KUEHL Jr F, Egan R . Leukotriene C4 binding to rat lung membranes. J Biol Chem. 1983; 258(16):9616-9. View

19.

Krilis S, Lewis R, Corey E, Austen K . Specific receptors for leukotriene C4 on a smooth muscle cell line. J Clin Invest. 1983; 72(4):1516-9. PMC: 370437. DOI: 10.1172/JCI111109. View

20.

Lee C, Lewis R, Tauber A, Mehrotra M, Corey E, Austen K . The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J Biol Chem. 1983; 258(24):15004-10. View